Proliferative vitreoretinopathy (PVR), or secondary scarring on and around the retina, is an
important cause of retinal re-detachment. The purpose of this study is to evaluate the effect
of oral isotretinoin, which inhibits the growth of cells responsible for proliferative
vitreoretinopathy (PVR), on recurrent retinal detachment.